Abstract
Purpose
To evaluate the clinical value of 18F-FDG-PET/CT for the diagnosis of fever of unknown origin (FUO) and inflammation of unknown origin (IUO) in Chinese population, as well as the characteristics of PET/CT in different category of etiological disease.
Methods
A total of 376 consecutive patients with FUO/IUO who underwent FDG-PET/CT at 12 hospitals were retrospectively studied. FDG uptake was quantitatively and visually evaluated, by using SUVmax and a 4-grade scale respectively. A questionnaire survey to the clinicians was used to evaluate the significance of PET/CT in diagnosing of FUO/IUO. Data analysis included the etiological distribution in the study population, image characteristics in different category of diseases, and clinical significance of PET/CT.
Results
In 376 studied patients, the infectious diseases accounted for 33.0% of patients, rheumatologic diseases for 32.4%, malignancies for 19.1%, miscellaneous causes for 6.6%, and cause unknown for 8.8%. However, the etiological distribution among hospitals was varied. In addition, the etiological disease composition ratio has changed over time in China. On PET/CT examinations, 358 (95.2%) of the patients had a positive finding. Within them, local high uptake lesion was found in 219 cases, and nonspecific abnormal uptake (NAU) was found in 187 cases. FDG uptake in malignant diseases was significantly higher than in other category diseases both on SUVmax and visual scores (t-value range from 4.098 to 5.612, all P value < 0.001). Based on a clinical questionnaire survey, PET/CT provided additional diagnostic information for 77.4% of patients, and 89.6% of patients benefited from PET/CT examination.
Conclusions
FDG PET/CT is a valuable tool for clinical diagnosis of FUO/IUO, and it is of great significance in further investigating the usefulness of PET/CT in non-neoplastic diseases.
Similar content being viewed by others
References
Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1–30.
Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152(1):21–2.
Durack DT, Street AC. Fever of unknown origin—reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.
de Kleijn EM, Knockaert DC, van der Meer JW. Fever of unknown origin: a new definition and proposal for diagnostic work-up. Eur J Intern Med. 2000;11(1):1–3.
Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253:263–75.
Vanderschueren S, Biondo ED, Ruttens D, et al. Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med. 2009;20:415–8.
Balink H, Bennink RJ, Veeger NJ, et al. Diagnostic utility of 18F-FDG PET/CT in inflammation of unknown origin. Clin Nucl Med. 2014;39(5):419–25.
Schönau V, Vogel K, Englbrecht M, et al. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77(1):70–7.
Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48(1):35–45.
Kouijzer IJ, Mulders-Manders CM, Bleeker-Rovers CP, et al. Fever of unknown origin: the value of FDG-PET/CT. Semin Nucl Med. 2018;48(2):100–7.
Vaidyanathan S, Patel CN, Scarsbrook AF, et al. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.
Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58.
Keidar Z, Gurman-Balbir A, Gaitini D, et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49(12):1980–5.
Ergül N, Halac M, Cermik TF, et al. The diagnostic role of FDG PET/CT in patients with fever of unknown origin. Mol Imaging Radionucl Ther. 2011;20(1):19–25.
Tokmak H, Ergonul O, Demirkol O, et al. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014;19:53–8.
Gafter-Gvili A, Raibman S, Grossman A, et al. [18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin. Q J Med. 2015;108(4):289–98.
Hung BT, Wang PW, Su YJ, et al. The efficacy of 18F-FDG PET/CT and 67Ga SPECT/CT in diagnosing fever of unknown origin. Int J Infect Dis. 2017;62:10–7.
Sioka C, Assimakopoulos A, Fotopoulos A. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin. Eur J Clin Invest. 2015;45(6):601–8.
Hess S, Hansson SH, Pedersen KT, et al. FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014;9(4):497–519. vi-vii
Pereira AM, Husmann L, Sah BR, et al. Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun. 2016;37(1):57–65.
Besson FL, Chaumet-Riffaud P, Playe M, et al. Contribution of 18F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis. Eur J Nucl Med Mol Imaging. 2016;43(10):1887–95.
Bleeker-Rovers CP, Vos FJ, Mudde AH, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34(5):694–703.
Chinese Society of Nuclear Medicine. Basic requirements of clinical quality control and quality assurance on SPECT (/CT) and PET/CT (2014 edition). Chin J Nucl Med Mol Imaging. 2014;343-448. Chinese.
Kubota K, Nakamoto Y, Tamaki N, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med. 2011;25:355–64.
Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.
Aide N, Lasnon C, Veit-Haibach P, et al. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):17–31.
Tan XY, He QY. Chinese literature review of etiology distribution of adult patients with fever of unknown origin from 1979 to 2012. Chin J Intern Med. 2013;52:1013–7. Chinese
Takeuchi M, Dahabreh IJ, Nihashi T, et al. Nuclear imaging for classic fever of unknown origin: meta-analysis. J Nucl Med. 2016;57(12):1913–9.
Yamashita H, Kubota K, Takahashi Y, et al. Clinical value of18F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Mod Rheumatol. 2014;24(26):645–50.
Dong MJ, Wang CQ, Zhao K, et al. 18F-FDG PET/CT in patients with adult-onset Still's disease. Clin Rheumatol. 2015;34(27):2047–56.
Pak K, Kim SJ, Kim IJ, et al. Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. Nucl Med Commun. 2013;34(25):64–70.
Mulders-Manders CM, Simon A, Bleeker-Rovers CP. Rheumatologic diseases as the cause of fever of unknown origin. Best Pract Res Clin Rheumatol. 2016;30:789–801.
Li Y, Zhou YS, Wang Q. Multiple values of 18F-FDG PET/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36:2297–305.
Li Y, Wang Q, Yue MG. Localization and etiologic diagnosis of suspected pacemaker-related infection with 18F-FDG PET/CT. Clin J Nucl Med Mol Imaging. 2017;37(4):284–8. Chinese
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
None.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent does not apply as this is a review manuscript.
Rights and permissions
About this article
Cite this article
Wang, Q., Li, YM., Li, Y. et al. 18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study. Eur J Nucl Med Mol Imaging 46, 159–165 (2019). https://doi.org/10.1007/s00259-018-4121-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-018-4121-1